Sinopharm is the Chinese company that GNBT has bee
Post# of 36537
(Total Views: 631)
Posted On: 10/10/2020 9:59:14 PM
Sinopharm is the Chinese company that GNBT has been working with to close the Covid vaccine, swine flu vaccine, and cancer vaccine platform contract, in a couple of week, I think.
https://pharmaboardroom.com/articles/top-10-c...companies/
China’s booming pharmaceutical industry has been rapidly expanding to become the second largest pharmaceutical market globally. The following are the top ten Chinese pharma companies from 2018, with revenues reaching over USD 1 billion.
Sinopharm Group
CEO: Yong Liu
HKEx 1099:HK
Sinopharm Group, the largest member of the China National Pharmaceutical Group, was officially established in 2003. The company engages in the research and development, manufacturing, distribution, and marketing of medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. The Group is considered the largest wholesaler and retailer of pharmaceutical and healthcare products in China, as well as a leading supply-chain service provider. The company listed on the Hong Kong Stock Exchange (HKEx) in 2009. Its total sales in 2018 reached more than USD 48 billion, far outpacing the other companies in the top 10 list.
https://pharmaboardroom.com/articles/top-10-c...companies/
China’s booming pharmaceutical industry has been rapidly expanding to become the second largest pharmaceutical market globally. The following are the top ten Chinese pharma companies from 2018, with revenues reaching over USD 1 billion.
Sinopharm Group
CEO: Yong Liu
HKEx 1099:HK
Sinopharm Group, the largest member of the China National Pharmaceutical Group, was officially established in 2003. The company engages in the research and development, manufacturing, distribution, and marketing of medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. The Group is considered the largest wholesaler and retailer of pharmaceutical and healthcare products in China, as well as a leading supply-chain service provider. The company listed on the Hong Kong Stock Exchange (HKEx) in 2009. Its total sales in 2018 reached more than USD 48 billion, far outpacing the other companies in the top 10 list.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼